Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > GUD things happening at ATE
View:
Post by GoldenInvestor on Nov 27, 2020 12:53pm

GUD things happening at ATE

ATE seems to be progressing well on their plan.  Good interview yesterday.

2 drugs nearing stage 3 in pain & inflammation & another
Comment by MrMugsy on Nov 27, 2020 1:34pm
Golden ... only one drug heading to Phase 3 but in a very large market.
Comment by GoldenInvestor on Nov 27, 2020 1:40pm
Yes!  Thanks for correcting my fast fingers. but they did speak of another drug, or therapeutic area , I think, in dev ? still,  even one drug , in a large market can be substantial ...
Comment by MrMugsy on Nov 27, 2020 2:05pm
Yes ... agreed. Knight needs to be part of the bidding for the first drug in South America. The second drug is preparing for human trials
Comment by Benedict16th on Nov 27, 2020 3:00pm
If you are looking for a real bang for your bucks why buy the tail of the dog "GUD" buy the real "dog" ATE. GUD and MNGT faith lies in GBT and time is running out as a 400 Million dollars good will buy out is not making money. If GBT does not turn around soon it will be a major irreversible financial embarrassment for GUD MNGT and the market will never trust them again. At ...more  
Comment by wagyusteak on Nov 27, 2020 3:08pm
gilead is there, Pfizer is there, big pharmacies all are there. Who is running???? Probably Meir. Lol. Oh wait, he's still holding GUD, so who??? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities